BFEC
KLRS

Benjamin F. Edwards & Company’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Benjamin F. Edwards & Company’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-68
Closed -$31K – 1777
2021
Q2 		$31K Buy
+68
New +$31K ﹤0.01% 1134